Pay in 4 interest-free payments of $5.94 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The Science Behind It
Gastrointestinal stromal tumors (GIST)
The brand combines medical treatments with nutritional guidance and lifestyle coaching
Although no data from head-to-head trials comparing retatrutide to other currently approved obesity treatments exist, data from the phase 2 studies with retatrutide suggest that at higher doses, retatrutide could lead to greater WL compared to the most efficacious approved treatments for obesity and T2D such as tirzepatide 15 mg and semaglutide 2.4 mg (Fig
Palliative chemotherapy with ifosfamide and doxorubicin was initiated
JAMA Netw Open 6:e237188
US$ 25.46
US$ 29.06
US$ 28.09
